76 research outputs found

    In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae

    Get PDF
    Actinobacillus pleuropneumoniae (A. pleuropneumoniae) is a Gram-negative bacterium that represents the main cause of porcine pleuropneumonia in pigs, causing significant economic losses to the livestock industry worldwide. A. pleuropneumoniae, as the majority of Gram-negative bacteria, excrete vesicles from its outer membrane (OM), accordingly defined as outer membrane vesicles (OMVs). Thanks to their antigenic similarity to the OM, OMVs have emerged as a promising tool in vaccinology. In this study we describe the in vivo testing of several vaccine prototypes for the prevention of infection by all known A. pleuropneumoniae serotypes. Previously identified vaccine candidates, the recombinant proteins ApfA and VacJ, administered individually or in various combinations with the OMVs, were employed as vaccination strategies. Our data show that the addition of the OMVs in the vaccine formulations significantly increased the specific IgG titer against both ApfA and VacJ in the immunized animals, confirming the previously postulated potential of the OMVs as adjuvant. Unfortunately, the antibody response raised did not translate into an effective protection against A. pleuropneumoniae infection, as none of the immunized groups following challenge showed a significantly lower degree of lesions than the controls. Interestingly, quite the opposite was true, as the animals with the highest IgG titers were also the ones bearing the most extensive lesions in their lungs. These results shed new light on A. pleuropneumoniae pathogenicity, suggesting that antibody-mediated cytotoxicity from the host immune response may play a central role in the development of the lesions typically associated with A. pleuropneumoniae infections

    Analysis of MABEL Bathymetry in Keweenaw Bay and Implications for ICESat-2 ATLAS

    No full text
    In 2018, the National Aeronautics and Space Administration (NASA) is scheduled to launch the Ice, Cloud, and land Elevation Satellite-2 (ICESat-2), with a new six-beam, green-wavelength, photon-counting lidar system, Advanced Topographic Laser Altimeter System (ATLAS). The primary objectives of the ICESat-2 mission are to measure ice-sheet elevations, sea-ice thickness, and global biomass. However, if bathymetry can be reliably retrieved from ATLAS data, this could assist in addressing a key data need in many coastal and inland water body areas, including areas that are poorly-mapped and/or difficult to access. Additionally, ATLAS-derived bathymetry could be used to constrain bathymetry derived from complementary data, such as passive, multispectral imagery and synthetic aperture radar (SAR). As an important first step in evaluating the ability to map bathymetry from ATLAS, this study involves a detailed assessment of bathymetry from the Multiple Altimeter Beam Experimental Lidar (MABEL), NASA’s airborne ICESat-2 simulator, flown on the Earth Resources 2 (ER-2) high-altitude aircraft. An interactive, web interface, MABEL Viewer, was developed and used to identify bottom returns in Keweenaw Bay, Lake Superior. After applying corrections for refraction and channel-specific elevation biases, MABEL bathymetry was compared against National Oceanic and Atmospheric Administration (NOAA) data acquired two years earlier. The results indicate that MABEL reliably detected bathymetry in depths of up to 8 m, with a root mean square (RMS) difference of 0.7 m, with respect to the reference data. Additionally, a version of the lidar equation was developed for predicting bottom-return signal levels in MABEL and tested using the Keweenaw Bay data. Future work will entail extending these results to ATLAS, as the technical specifications of the sensor become available
    corecore